Cargando…
Aspartame and Phe-Containing Degradation Products in Soft Drinks across Europe
Phenylketonuria and tyrosinemia type 1 are treated with dietary phenylalanine (Phe) restriction. Aspartame is a Phe-containing synthetic sweetener used in many products, including many ‘regular’ soft drinks. Its amount is (often) not declared; therefore, patients are advised not to consume aspartame...
Autores principales: | van Vliet, Kimber, Melis, Elise S., de Blaauw, Pim, van Dam, Esther, Maatman, Ronald G. H. J., Abeln, David, van Spronsen, Francjan J., Heiner-Fokkema, M. Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353418/ https://www.ncbi.nlm.nih.gov/pubmed/32599819 http://dx.doi.org/10.3390/nu12061887 |
Ejemplares similares
-
Dried blood spot versus venous blood sampling for phenylalanine and tyrosine
por: van Vliet, Kimber, et al.
Publicado: (2020) -
Presumptive brain influx of large neutral amino acids and the effect of phenylalanine supplementation in patients with Tyrosinemia type 1
por: van Ginkel, Willem G., et al.
Publicado: (2017) -
Important Lessons on Long-Term Stability of Amino Acids in Stored Dried Blood Spots
por: Dijkstra, Allysa M., et al.
Publicado: (2023) -
Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU)
por: Bruinenberg, Vibeke M., et al.
Publicado: (2019) -
Preventive use of nitisinone in alkaptonuria
por: Wolffenbuttel, Bruce H. R., et al.
Publicado: (2021)